Treatment of Resistant Pseudomonas Aeruginosa Infections (AAC ed.)

<p>Infections caused by multidrug-resistant <em>Pseudomonas aeruginosa</em> are considered a major public health problem. Antibiotic options are scarce but new drugs are emerging and more maybe available in the near future.</p> <h2><strong>Topics discussed:</strong></h2> <ul> <li><em>Pseudomonas aeruginosa</em> as an important pathogen capable of developing resistance to multiple antibiotics</li> <li>Common mechanisms of resistance in <em>Pseudomonas aeruginosa</em></li> <li>The current and future approaches for these MDR organisms.</li> </ul> <h2><strong>Guests:</strong></h2> <ul> <li>Michael Satlin, MD, Associate Professor of Medicine, Pathology and Laboratory Medicine, William Randolph Hearst Foundation Clinical Scholar in Microbiology and Infectious Diseases at Weill Cornell Medical College, New York, NY</li> <li>Alessandra Carattoli, PhD, Professor of Microbiology at the Sapienza University of Rome, Italy. Editor, AAC</li> </ul> <p dir="ltr">Visit <a href="https://journals.asm.org/journal/aac" target="_blank" rel="noopener">journals.asm.org/journal/aac</a> to browse issues and/or submit a manuscript.</p>